Jeffrey A. Meckler
CEO and Vice Chairman of the Board
INTEC PHARMA LTD.
Mr. Meckler has held a variety of roles over in both large and small biopharma companies. Most recently, Mr. Meckler was the CEO of Cocrystal Pharma, transforming it into a clinical company. Additionally, he has held led companies like QLT, Inc. and Cypress Bioscience through transformational times. Mr. Meckler is currently a director and former Chairman of Retrophin. Mr. Meckler started his career in life sciences with Pfizer, Inc., eventually becoming a member of the Corporate Finance Leadership Team and overseeing acquisition and divestiture activities. Mr. Meckler holds a B.S. in Industrial Management and a M.S. in Industrial Administration from the Tepper School of Business at Carnegie Mellon University. Additionally, he received his J.D. from Fordham University’s School of Law.